Drug
Tafluprost
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Ocular Hyperaemia | 464 | 72.4 | 85.9 | signal |
| 2 | Eye Irritation | 425 | 55.4 | 64.8 | signal |
| 3 | Intraocular Pressure Increased | 97 | 54.9 | 56.8 | signal |
| 4 | Eye Pruritus | 230 | 50.7 | 55.0 | signal |
| 5 | Eye Pain | 293 | 38.5 | 42.7 | signal |
| 6 | Photophobia | 86 | 33.4 | 34.4 | signal |
| 7 | Eye Discharge | 42 | 29.8 | 30.2 | signal |
| 8 | Ocular Discomfort | 39 | 26.0 | 26.3 | signal |
| 9 | Eye Swelling | 122 | 23.9 | 24.9 | signal |
| 10 | Eye Inflammation | 25 | 19.2 | 19.3 | signal |
| 11 | Lacrimation Increased | 74 | 17.9 | 18.4 | signal |
| 12 | Dry Eye | 110 | 16.4 | 17.0 | signal |
| 13 | Glaucoma | 41 | 15.4 | 15.6 | signal |
| 14 | Eyelid Oedema | 17 | 10.5 | 10.5 | signal |
| 15 | Vision Blurred | 174 | 9.2 | 9.7 | signal |
| 16 | Eye Infection | 12 | 7.7 | 7.8 | signal |
| 17 | Eye Haemorrhage | 14 | 7.6 | 7.6 | signal |
| 18 | Incorrect Product Storage | 13 | 7.0 | 7.1 | signal |
| 19 | Retinal Detachment | 8 | 6.3 | 6.3 | signal |
| 20 | Emphysema | 8 | 5.7 | 5.7 | signal |
| 21 | Visual Acuity Reduced | 26 | 5.6 | 5.6 | signal |
| 22 | Uveitis | 10 | 5.3 | 5.4 | signal |
| 23 | Vitreous Floaters | 7 | 5.2 | 5.2 | signal |
| 24 | Poor Quality Product Administered | 7 | 4.9 | 5.0 | signal |
| 25 | Intervertebral Disc Degeneration | 6 | 4.7 | 4.7 | signal |
| 26 | Madarosis | 7 | 4.3 | 4.3 | signal |
| 27 | Blindness Unilateral | 8 | 4.1 | 4.1 | signal |
| 28 | Product Packaging Quantity Issue | 6 | 4.0 | 4.0 | signal |
| 29 | Conjunctivitis | 10 | 3.9 | 3.9 | signal |
| 30 | Product Packaging Issue | 5 | 3.9 | 3.9 | signal |
| 31 | Adverse Reaction | 7 | 3.8 | 3.8 | signal |
| 32 | Head Discomfort | 9 | 3.7 | 3.7 | signal |
| 33 | Dry Throat | 5 | 3.6 | 3.6 | signal |
| 34 | Eyelid Ptosis | 5 | 3.5 | 3.6 | signal |
| 35 | Device Use Issue | 8 | 3.3 | 3.3 | signal |
| 36 | Product Administration Error | 9 | 3.3 | 3.3 | signal |
| 37 | Blindness | 18 | 3.2 | 3.2 | signal |
| 38 | Cataract | 26 | 3.2 | 3.2 | signal |
| 39 | Visual Impairment | 50 | 2.9 | 3.0 | signal |
| 40 | Eye Disorder | 13 | 2.9 | 2.9 | signal |
| 41 | Hernia | 7 | 2.6 | 2.6 | signal |
| 42 | Brain Neoplasm | 3 | 2.4 | 2.4 | no signal |
| 43 | Gastric Cancer | 7 | 2.0 | 2.0 | no signal |
| 44 | Product Quality Issue | 35 | 1.9 | 1.9 | no signal |
| 45 | Product Taste Abnormal | 3 | 1.6 | 1.6 | no signal |
| 46 | Expired Product Administered | 7 | 1.5 | 1.5 | no signal |
| 47 | Pancreatic Carcinoma | 6 | 1.5 | 1.5 | no signal |
| 48 | No Adverse Event | 32 | 1.3 | 1.3 | no signal |
| 49 | Skin Irritation | 8 | 1.3 | 1.3 | no signal |
| 50 | Product Storage Error | 15 | 1.3 | 1.3 | no signal |
| 51 | Hepatic Cancer | 4 | 1.2 | 1.2 | no signal |
| 52 | Product Complaint | 4 | 1.2 | 1.2 | no signal |
| 53 | Injury Associated With Device | 3 | 1.1 | 1.1 | no signal |
| 54 | Drug Dose Omission | 25 | 1.1 | 1.1 | no signal |
| 55 | Circumstance Or Information Capable Of Leading To Medication Error | 5 | 1.1 | 1.1 | no signal |
| 56 | Exposure Via Skin Contact | 3 | 1.0 | 1.0 | no signal |
| 57 | Accidental Exposure To Product | 12 | 0.9 | 0.9 | no signal |
| 58 | Bladder Cancer | 4 | 0.5 | 0.5 | no signal |
| 59 | Device Difficult To Use | 3 | 0.3 | 0.3 | no signal |